Search research articles
Contact Us
Filters
Showing results (81-90 of 207) with videos related to
Page
of 21
Sort By:
Cold Spring Harbor Molecular Case Studies
|
December 1, 2016
A patient with multisystem dysfunction carries a truncation mutation in human <i>SLC12A2</i>, the gene encoding the Na-K-2Cl cotransporter, NKCC1
Eric Delpire, Lynne Wolfe, Bianca Flores, et al.
Cellular Signalling
|
December 30, 2014
Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains
Graeme B Bolger, Allan J Dunlop, Dong Meng, et al.
Cellular Signalling
|
July 6, 2010
p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways
Frank Christian, Diana F Anthony, Surakiran Vadrevu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2011
Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast
Robert W Allcock, Haakon Blakli, Zhong Jiang, et al.
Molecular Genetics and Metabolism
|
February 6, 2016
The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine
William A Gahl, John J Mulvihill, Camilo Toro, et al.
BMC Medical Genomics
|
August 29, 2016
Explorations to improve the completeness of exome sequencing
Chen Du, Barbara N Pusey, Christopher J Adams, et al.
Cellular Signalling
|
December 10, 2020
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis
Stephanie Schwalm, Sandra Beyer, Redona Hafizi, et al.
Biofouling
|
November 19, 2003
The development of a marine natural product-based antifouling paint
J Grant Burgess, Kenneth G Boyd, Evelyn Armstrong, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2012
Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration
Koji Ochiai, Satoshi Takita, Akihiko Kojima, et al.
Scientific Reports
|
March 24, 2017
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1
Euan Parnell, Stuart P McElroy, Jolanta Wiejak, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 207) with videos related to
Sort By:
Page
of 21
Cold Spring Harbor Molecular Case Studies
|
December 1, 2016
A patient with multisystem dysfunction carries a truncation mutation in human <i>SLC12A2</i>, the gene encoding the Na-K-2Cl cotransporter, NKCC1
Eric Delpire, Lynne Wolfe, Bianca Flores, et al.
Cellular Signalling
|
December 30, 2014
Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains
Graeme B Bolger, Allan J Dunlop, Dong Meng, et al.
Cellular Signalling
|
July 6, 2010
p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways
Frank Christian, Diana F Anthony, Surakiran Vadrevu, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 3, 2011
Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast
Robert W Allcock, Haakon Blakli, Zhong Jiang, et al.
Molecular Genetics and Metabolism
|
February 6, 2016
The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine
William A Gahl, John J Mulvihill, Camilo Toro, et al.
BMC Medical Genomics
|
August 29, 2016
Explorations to improve the completeness of exome sequencing
Chen Du, Barbara N Pusey, Christopher J Adams, et al.
Cellular Signalling
|
December 10, 2020
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis
Stephanie Schwalm, Sandra Beyer, Redona Hafizi, et al.
Biofouling
|
November 19, 2003
The development of a marine natural product-based antifouling paint
J Grant Burgess, Kenneth G Boyd, Evelyn Armstrong, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2012
Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration
Koji Ochiai, Satoshi Takita, Akihiko Kojima, et al.
Scientific Reports
|
March 24, 2017
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1
Euan Parnell, Stuart P McElroy, Jolanta Wiejak, et al.
Page
of 21